SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-030739
Filing Date
2020-03-09
Accepted
2020-03-09 16:01:32
Documents
3
Period of Report
2020-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012102_8k.htm 8-K 18913
2 EXHIBIT 99.1 tm2012102_ex99-1.htm EX-99.1 72037
3 GRAPHIC logo.jpg GRAPHIC 3827
  Complete submission text file 0001104659-20-030739.txt   97646
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 20697946
SIC: 2834 Pharmaceutical Preparations